- Home
- CANF vs RMCF Comparison
CANF vs RMCF Comparison
Compare CANF & RMCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CANF
- RMCF
- Stock Information
- Founded
- CANF 1994
- RMCF 1981
- Country
- CANF Israel
- RMCF United States
- Employees
- CANF N/A
- RMCF N/A
- Industry
- CANF Biotechnology: Pharmaceutical Preparations
- RMCF Specialty Foods
- Sector
- CANF Health Care
- RMCF Consumer Staples
- Exchange
- CANF Nasdaq
- RMCF Nasdaq
- Market Cap
- CANF 14.4M
- RMCF 14.3M
- IPO Year
- CANF N/A
- RMCF N/A
- Fundamental
- Price
- CANF $2.46
- RMCF $2.13
- Analyst Decision
- CANF Strong Buy
- RMCF
- Analyst Count
- CANF 2
- RMCF 0
- Target Price
- CANF $14.00
- RMCF N/A
- AVG Volume (30 Days)
- CANF 137.2K
- RMCF 16.2K
- Earning Date
- CANF 11-15-2024
- RMCF 10-15-2024
- Dividend Yield
- CANF N/A
- RMCF N/A
- EPS Growth
- CANF N/A
- RMCF N/A
- EPS
- CANF N/A
- RMCF N/A
- Revenue
- CANF $667,000.00
- RMCF $27,921,687.00
- Revenue This Year
- CANF $356.93
- RMCF N/A
- Revenue Next Year
- CANF N/A
- RMCF N/A
- P/E Ratio
- CANF N/A
- RMCF N/A
- Revenue Growth
- CANF N/A
- RMCF N/A
- 52 Week Low
- CANF $1.81
- RMCF $1.50
- 52 Week High
- CANF $4.69
- RMCF $5.15
- Technical
- Relative Strength Index (RSI)
- CANF 62.91
- RMCF 60.14
- Support Level
- CANF $1.87
- RMCF $1.95
- Resistance Level
- CANF $2.55
- RMCF $2.04
- Average True Range (ATR)
- CANF 0.17
- RMCF 0.10
- MACD
- CANF 0.06
- RMCF 0.02
- Stochastic Oscillator
- CANF 85.94
- RMCF 59.39
About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)
Can Fite Biofarma Ltd is an clinical-stage biopharmaceutical company. The company develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases. The company's platform technology utilizes the Gi protein associated A3 adenosine receptor, or A3AR, as a therapeutic target. The company's drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis. Can-Fite's liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC), the common form of liver cancer, and a Phase IIb trial for the treatment of non-alcoholic steatohepatitis (NASH).
About RMCF Rocky Mountain Chocolate Factory Inc.
Rocky Mountain Chocolate Factory Inc operates as a manufacturer of chocolate candies and confectionery products. The business activity of the firm functions through Franchising, Manufacturing, Retail Stores, U-Swirl Operations, and Other t. The products of the company include varieties of Clusters, Caramels, Creams, Toffees, Mints, and Truffles.